Tag Archives: Prof Brett Lidbury

Biomedical insights that inform the diagnosis of ME/CFS

Biomedical insights that inform the diagnosis of ME/CFS, by Brett A Lidbury, & Paul R Fisher, in Diagnostics 2020, 10(2), 92; [doi.org/10.3390/diagnostics10020092] (This article belongs to the Special Issue Biomedical Insights that Inform the Diagnosis of ME/CFS)   Editorial announcing … Continue reading

Posted in News | Tagged , , , | Comments Off on Biomedical insights that inform the diagnosis of ME/CFS

An isolated complex V inefficiency & dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients

An isolated complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients, by Daniel Missailidis, Sarah J Annesley, Claire Y Allan, Oana Sanislav, Brett A Lidbury, Donald P Lewis and Paul R Fisher in J. Mol. Sci. … Continue reading

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on An isolated complex V inefficiency & dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients

Towards a biomarker: Rethinking ME/CFS diagnostic reference intervals via machine learning, & the utility of activin B for defining symptom severity

Rethinking ME/CFS diagnostic reference intervals via machine learning, and the utility of activin B for defining symptom severity, by Brett A. Lidbury, Badia Kita, Alice M Richardson, Donald P Lewis, Edwina Privitera, Susan Hayward, David de Kretser and Mark Hedger … Continue reading

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on Towards a biomarker: Rethinking ME/CFS diagnostic reference intervals via machine learning, & the utility of activin B for defining symptom severity

ME/CFS: a comprehensive review

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a comprehensive review, by Mateo Cortes Rivera, Claudio Mastronardi, Claudia T Silva-Aldana, Mauricio Arcos-Burgos and Brett A Lidbury in Diagnostics 2019, 9(3), 91; 7 August 2019[https://doi.org/10.3390/diagnostics9030091] Review abstract: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , | Comments Off on ME/CFS: a comprehensive review

Weighted Standing Time test as a measure of orthostatic intolerance in ME/CFS

Research abstract: Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection, by Alice M. Richardson, Don P. Lewis, Badia Kita, Helen Ludlow, Nigel P. Groome, Mark P. Hedger, David M. de Kretser, Brett A. Lidbury in Journal … Continue reading

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on Weighted Standing Time test as a measure of orthostatic intolerance in ME/CFS

Could we finally have a definitive biomarker for ME/CFS?

ME Research UK blog post, 9 June 2017: Could we finally have a definitive biomarker for ME/CFS? It’s a recurring theme, but the diagnosis of ME/CFS is severely hampered by the lack of a test that can distinguish people with … Continue reading

Posted in News | Tagged , , , | Comments Off on Could we finally have a definitive biomarker for ME/CFS?

Activin B – a potential biomarker for CFS/ME?

Research abstract: Background: Investigations of activin family proteins as serum biomarkers for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). CFS/ME is a disease with complex, wide-ranging symptoms, featuring persistent fatigue of 6 months or longer, particularly post exertion. No definitive biomarkers are … Continue reading

Posted in News | Tagged , , , | Comments Off on Activin B – a potential biomarker for CFS/ME?

New Australian genetic marker detection study

ME Research UK blog post, 6 November 2016: New study – Genetic marker detection Prof Brett Lidbury and colleagues at the John Curtin School of Medical Research, Australian National University in Canberra are conducting an ongoing programme, funded by charities in … Continue reading

Posted in News | Tagged , , , , | Comments Off on New Australian genetic marker detection study